Kbc Group Nv Dyne Therapeutics, Inc. Transaction History
Kbc Group Nv
- $32.2 Billion
- Q1 2025
A detailed history of Kbc Group Nv transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 3,135 shares of DYN stock, worth $32,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,135
Previous 3,135
-0.0%
Holding current value
$32,729
Previous $74,000
55.41%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$108 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$101 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$95.3 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$77.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$77.1 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $540M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...